Real Estate & Property DevelopmentCompanies & operators

Pruksa Holding

Pruksa Holding (SET: PSH) is Thailand's mass-market, affordable-housing residential specialist. FY2024 consolidated revenue approximately THB 27B. Core franchise targets the mass, lower-mid segment (detached THB 2-6M, townhouse THB 1.5-4M, condo THB 1-3M per unit); buyer profile skews younger, first-home, higher LTV dependence. Pruksa's precast-concrete construction arm (Pruksa Precast) is a vertical integration that drives cost-of-goods discipline on high-volume mass-market product. The Vimut Hospital healthcare joint venture is a strategic diversification into private healthcare; remains small relative to core residential but signals group-level diversification intent.

Snapshot

Headline numbers a buyer checks first.

FY2024 revenue

~THB 27B

FY2024

Segment

Mass-market, affordable

FY2024

Ticker

SET: PSH

Listed 2005

Integration

Precast concrete, healthcare JV

FY2024

What this company actually does

Pruksa's core business is high-volume mass-market residential: detached house, townhouse, condo targeting first-home, lower-mid-income buyers. Product-brand ladders: Pruksa Ville (detached, townhouse), Baan Pruksa (affordable townhouse), The Connect (mid townhouse), Plum Condo (affordable condo), The Tree (mid condo). Pruksa Precast operates factory-scale precast-concrete production in Bangkok, BMR, supplying internally to Pruksa residential, externally to third-party developers. Vimut Hospital (JV with private-healthcare partners) is a vertical diversification but generates a single-digit-percent share of group revenue.[]

Strategic position, cycle exposure: Pruksa is the listed-stack entry-level consumer-real-estate beta. Mass-market, first-home buyer profile is the most LTV-exposed cohort in the Thai residential market; BOT LTV tightening compresses Pruksa presales disproportionately. Offset is precast-concrete cost-of-goods integration, disciplined pricing. Competitive set: LPN Development (mass-condo peer), smaller private mass-market developers. Upside to Pruksa comes from BOT LTV relaxation, household-debt moderation — both variables outside company control.[, ]

Pruksa Holding FY2024 56-1Pruksa Precast, Vimut Hospital subsidiary disclosures
Data as of: FY2024

Business segments

Mass-market housing

Townhouse, detached, affordable condo

Core revenue: high-volume affordable townhouse ($0.043-4M), detached house ($0.058-6M), affordable condo ($0.029-3M/unit). Brands: Baan Pruksa, Pruksa Ville, The Connect, Plum Condo, The Tree.

Precast integration

Pruksa Precast — cost discipline

Factory-scale precast-concrete production supplying Pruksa residential divisions and third-party developers. Internal supply lowers cost-of-goods; third-party revenue provides incremental income stream.

Healthcare JV

Vimut Hospital

Vimut Hospital joint venture with private-healthcare partners. Single-digit percent of group revenue but strategic diversification signal. Private hospital market benefits from Thailand aging demographics.

Scale

FY2024 revenue ~THB 27B

FY2024 consolidated revenue approximately $782.6M. Mass-market residential segment accounts for ~90%+ of consolidated revenue. Positioned as listed-market entry-level residential beta.

Thai residential developer peer comparison

Listed residential developers, approximate FY2024 positioning

Pruksa Holding

Ticker

SET:PSH

FY2024 revenue

~ $782.6M

Target segment

Mass-market, affordable

LPN Development

Ticker

SET:LPN

FY2024 revenue

~ $260.9M

Target segment

Mass-market urban condo

Supalai

Ticker

SET:SPALI

FY2024 revenue

~ $869.6M

Target segment

Mass-to-mid, multi-segment

AP Thailand

Ticker

SET:AP

FY2024 revenue

~ $1.16B

Target segment

Mid-to-upper, condo

Key drivers 2025-2026

LTV policy

BOT mortgage-loan rules

Mass-market, first-home buyer profile is most LTV-ratio-dependent. BOT LTV relaxation or tightening is the single largest external variable for Pruksa presales momentum.

Household debt

Thai consumer debt serviceability

Thai household debt at ~90% of GDP constrains first-home buyer mortgage approval rates. Debt moderation or income growth unlocks mass-market presale conversion.

Healthcare diversification

Vimut scaling trajectory

Vimut Hospital FY2025 revenue growth and bed-occupancy trajectory signals whether healthcare JV justifies increased capital allocation vs residential core.

Watchpoints

BOT LTV, first-home origination

Mass-market buyer profile most LTV-exposed; BOT tightening compresses Pruksa fastest.

Precast-concrete cost discipline

Internal supply, third-party precast revenue; cost-of-goods moat.

Vimut Hospital trajectory

Healthcare JV scaling; remains single-digit group-revenue share but diversification signal.

Mass-condo oversupply

Pruksa, LPN compete in a segment with persistent unsold-inventory overhang.

Related Market profiles

Peers, parents, partners, agencies, and other Real Estate & Property Development actors.

Sources + data provenance

Every filing, filing-adjacent register, or trusted industry source cited in this profile.

Pruksa Holding PCL (SET: PSH) FY2024 Form 56-1 One Report

Publisher

Pruksa Holding PCL

Grade

Primary

As of

2025-03-31

Bank of Thailand — Loan-to-Value (LTV) Macro-prudential Measures

Grade

Primary

As of

2026-04-01

Auto-generated from the company source registry.
Primary filings are the first choice. Trusted industry research (Fitch, S&P, Moody's, Opensignal, GSMA, Omdia, JLL, Knight Frank, CBRE, Colliers, STR, etc.) is used for triangulation per SOP — never as the sole anchor.

Reports featuring this profile

Related Market profiles

Key statistics for this sector

Pruksa Holding - Market Atlas · Insight